EKF Diagnostics (LON:EKF – Get Free Report) issued its earnings results on Tuesday. The company reported GBX 0.54 earnings per share (EPS) for the quarter, Digital Look Earnings reports. EKF Diagnostics had a net margin of 4.12% and a return on equity of 3.01%.
EKF Diagnostics Price Performance
Shares of LON EKF traded down GBX 0.60 during midday trading on Wednesday, reaching GBX 25. The stock had a trading volume of 191,987 shares, compared to its average volume of 326,429. The company has a market capitalization of £107.04 million, a price-to-earnings ratio of 53.19 and a beta of 0.50. The company has a debt-to-equity ratio of 2.01, a quick ratio of 1.77 and a current ratio of 4.16. The stock has a 50-day moving average of GBX 25.45 and a 200-day moving average of GBX 25.51. EKF Diagnostics has a 12-month low of GBX 22 and a 12-month high of GBX 31.70.
EKF Diagnostics Company Profile
● Point-of-Care analysers in the key areas of Hematology and Diabetes
● Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic, food and industrial applications.
EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide.
Read More
- Five stocks we like better than EKF Diagnostics
- 5 Buy-and-Hold Stocks Built to Weather a Volatile Market
- Movado’s Turnaround Gains Momentum
- Qualcomm’s Discount Could Vanish If Its AI Bet Pays Off
- Micron’s AI Memory Boom Could Send Shares 100% Higher
Receive News & Ratings for EKF Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EKF Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
